Catalyst Wire Dossier Catalyst Wire Dossier

Icaritin Soft Capsule

icaritin · Beijing Shenogen Biomedical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Icaritin Soft Capsule, covering 2023-06-15 to 2024-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP) [Phase 3]

See pricing